AlphaCentric Advisors’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$350K Buy
+14,322
New +$399K 0.31% 102

Other funds holding BEAM

AlphaCentric Advisors's BEAM Position: Q3 2026 in Review

AlphaCentric Advisors opened a new position in Beam Therapeutics (BEAM) in Q3 2026: 14,322 shares worth $350K. The stake represents 0.31% of the portfolio and ranks #102 among its holdings.

220 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.

  • AlphaCentric Advisors held 14,322 shares of Beam Therapeutics worth $350K as of Q3 2026.
  • Beam Therapeutics was a new AlphaCentric Advisors position in Q3 2026.
  • Beam Therapeutics made up 0.31% of AlphaCentric Advisors's portfolio in Q3 2026, its #102 holding.
  • 220 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.

Based on AlphaCentric Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.